Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.
about
Non-contact electromagnetic induction heating for eradicating bacteria and yeasts on biomaterials and possible relevance to orthopaedic implant infections: In vitro findings.Clinical and Microbiological Characteristics of Heteroresistant and Vancomycin-Intermediate Staphylococcus aureus from Bloodstream Infections in a Brazilian Teaching HospitalEfflux Pump Overexpression Contributes to Tigecycline Heteroresistance in Salmonella enterica serovar Typhimurium.Neuropsychiatric Effects of Antimicrobial Agents.Environmental and genetic modulation of the phenotypic expression of antibiotic resistance.Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.Identification of Staphylococcus aureus Cellular Pathways Affected by the Stilbenoid Lead Drug SK-03-92 Using a Microarray.Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA.The synergistic effect of PDT and oxacillin on clinical isolates of Staphylococcus aureus.
P2860
Q33759740-841C9CAE-70FA-442E-A0CD-5785D4B64607Q36116970-FEBACEA0-10CB-4C9F-B42E-3B4342DAF91EQ37647640-66B32E79-535F-4DA2-B487-7FCB87BF7938Q39135986-536E5E6E-79A0-4A8A-9ADD-9FDA37A8F80BQ39195574-9961FA36-0BDD-4089-BC08-682A4E09AEE9Q40320011-F66E248E-2A78-46C2-9665-1CD9F639B6ABQ41662667-E7FBB349-0292-4909-97E3-731D3B812B32Q41869403-2759C7A2-41F8-49FF-A196-C73C7726CE7DQ50048678-5D9DD8F9-883A-4418-9ABB-660702BB4691
P2860
Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clinical implications of vanco ...... eptible Staphylococcus aureus.
@en
type
label
Clinical implications of vanco ...... eptible Staphylococcus aureus.
@en
prefLabel
Clinical implications of vanco ...... eptible Staphylococcus aureus.
@en
P2093
P2860
P356
P1433
P1476
Clinical implications of vanco ...... eptible Staphylococcus aureus.
@en
P2093
Diane M Gomes
Kerry L LaPlante
Kristina E Ward
P2860
P304
P356
10.1002/PHAR.1577
P407
P577
2015-04-01T00:00:00Z